Non-Hodgkin lymphoma biopsy: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Non-Hodgkin lymphoma}} {{CMG}}; {{AE}} {{AS}} ==Overview== Lymph node or extra nodal tissue biopsy is diagnostic of Non-Hodgkin lymphoma. ==Biopsy== * Lymph node o...")
 
No edit summary
 
(4 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Non-Hodgkin lymphoma}}
{{Non-Hodgkin lymphoma}}
{{CMG}}; {{AE}} {{AS}}
{{CMG}}; {{AE}} {{Preeti}}
==Overview==
==Overview==
Lymph node or extra nodal tissue biopsy is diagnostic of Non-Hodgkin lymphoma.
[[Lymph node]] or extranodal tissue [[biopsy]] is diagnostic of non-Hodgkin lymphoma.
 
==Biopsy==
==Biopsy==
* Lymph node or extra nodal tissue biopsy is diagnostic of Non-Hodgkin lymphoma.
*[[Lymph node]] or extranodal tissue [[biopsy]] is diagnostic of non-Hodgkin lymphoma.<ref name="pmid28332735">{{cite journal| author=Intragumtornchai T, Bunworasate U, Wudhikarn K, Lekhakula A, Julamanee J, Chansung K et al.| title=Non-Hodgkin lymphoma in South East Asia: An analysis of the histopathology, clinical features, and survival from Thailand. | journal=Hematol Oncol | year= 2018 | volume= 36 | issue= 1 | pages= 28-36 | pmid=28332735 | doi=10.1002/hon.2392 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28332735  }}</ref><ref name="pmid25499449">{{cite journal| author=Casulo C, Burack WR, Friedberg JW| title=Transformed follicular non-Hodgkin lymphoma. | journal=Blood | year= 2015 | volume= 125 | issue= 1 | pages= 40-7 | pmid=25499449 | doi=10.1182/blood-2014-04-516815 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25499449  }}</ref><ref>Bain BJ, Clark DM, Lampert IA, Wilkins BS, editors. Bone marrow pathology. 3 rd ed. UK: Blackwell Science Ltd; 2001.</ref><ref>Bartl R, Frisch B, Burkhardt R, Jδger K, Pappenberger R, Hoffmann-Fezer G. Lymphoproliferations in bone marrow: i0 dentification and evaluation, classification and staging. J Clin Pathol 1984;37:233-54.</ref>
*Biopsy findings vary in morphologic features depending on the specific subtype.
*The abnormal lymphocytes in the lymph node, bone marrow, or extranodal sites can be subdivided as small cleaved or noncleaved, intermediate, or large cell and can have a follicular or diffuse pattern.
*Lymphomas usually alter the lymph node architecture, and the capsule is usually involved.
 
==References==
==References==
{{reflist|2}}
{{reflist|2}}


{{Hematology}}
[[Category:Up-To-Date]]
{{Hematological malignancy histology}}
[[Category:Oncology]]
 
[[Category:Medicine]]
[[Category:Hematology]]
[[Category:Hematology]]
[[Category:Types of cancer]]
[[Category:Immunology]]
[[Category:Disease]]
 
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 21:21, 20 January 2019

Non-Hodgkin lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Non-Hodgkin's Lymphoma

Differentiating Non-Hodgkin Lymphoma from Other Diseases
Differentiating Types of Non-Hodgkin's Lymphoma

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Biopsy

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Non-Hodgkin lymphoma biopsy On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Non-Hodgkin lymphoma biopsy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Non-Hodgkin lymphoma biopsy

CDC on Non-Hodgkin lymphoma biopsy

Non-Hodgkin lymphoma biopsy in the news

Blogs on Non-Hodgkin lymphoma biopsy

Directions to Hospitals Treating Non-Hodgkin lymphoma

Risk calculators and risk factors for Non-Hodgkin lymphoma biopsy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Preeti Singh, M.B.B.S.[2]

Overview

Lymph node or extranodal tissue biopsy is diagnostic of non-Hodgkin lymphoma.

Biopsy

  • Lymph node or extranodal tissue biopsy is diagnostic of non-Hodgkin lymphoma.[1][2][3][4]
  • Biopsy findings vary in morphologic features depending on the specific subtype.
  • The abnormal lymphocytes in the lymph node, bone marrow, or extranodal sites can be subdivided as small cleaved or noncleaved, intermediate, or large cell and can have a follicular or diffuse pattern.
  • Lymphomas usually alter the lymph node architecture, and the capsule is usually involved.

References

  1. Intragumtornchai T, Bunworasate U, Wudhikarn K, Lekhakula A, Julamanee J, Chansung K; et al. (2018). "Non-Hodgkin lymphoma in South East Asia: An analysis of the histopathology, clinical features, and survival from Thailand". Hematol Oncol. 36 (1): 28–36. doi:10.1002/hon.2392. PMID 28332735.
  2. Casulo C, Burack WR, Friedberg JW (2015). "Transformed follicular non-Hodgkin lymphoma". Blood. 125 (1): 40–7. doi:10.1182/blood-2014-04-516815. PMID 25499449.
  3. Bain BJ, Clark DM, Lampert IA, Wilkins BS, editors. Bone marrow pathology. 3 rd ed. UK: Blackwell Science Ltd; 2001.
  4. Bartl R, Frisch B, Burkhardt R, Jδger K, Pappenberger R, Hoffmann-Fezer G. Lymphoproliferations in bone marrow: i0 dentification and evaluation, classification and staging. J Clin Pathol 1984;37:233-54.